Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Exuma Biotech logo

Exuma Biotech

Recent Finacing

Series B

Recent Raise

$19M

Exuma Biotech (formerly F1 Oncology) is a clinical-stage developer of CAR-T therapies that builds logic-gated, tumor-microenvironment-restricted and same-day point-of-care CAR-T platforms using globally integrated R&D and informatics teams.

Founded 2015
Midland, Cayman Islands
51-100
Private
exumabio.com

Highlights

Focus Areas

Big Data
Biotechnology
Health Care
Medical

Recent Investors

MSD Partners logo
F1 BioVentures logo

Financials

$29M

Total Raised

2

Funding rounds

2

Investors


Team

Upgrade to view the team

See the team members at Exuma Biotech.